Clinical Trial Update: Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating switching Enfuvirtide to Raltegravir in HIV-infected subjects; results completed and posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Enfuvirtide (enfuvirtide)
• Raltegravir (raltegravir)

Snippet

Sponsor: Kaiser Permanente | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-06-08